Actively Recruiting
Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease
Led by Association HGE CHU Bordeaux Sud · Updated on 2023-07-20
10000
Participants Needed
1
Research Sites
1043 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this retrospective and prospective study is to evaluate the 20-year prognosis value of non-invasive methods for the diagnosis of chronic liver disease for predicting survival and complications of cirrhosis.
CONDITIONS
Official Title
Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have chronic hepatitis C
- Have chronic hepatitis B
- Have alcoholic liver disease
- Have non-alcoholic liver disease
You will not qualify if you...
- Have ascites
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre d'Investigation de la Fibrose hépatique Service Hépato-Gastroentérologie Hopital Haut-Lévèque
Pessac, France, 33200
Actively Recruiting
Research Team
V
Victor de Lédinghen, MD, PhD
CONTACT
J
Juliette Foucher
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here